Connective tissue growth factor (CTGF) from basics to clinics

Yasaman Ramazani, Noël Knops, Mohamed A. Elmonem, Tri Q. Nguyen, Fanny Oliveira Arcolino, Lambert van den Heuvel, Elena Levtchenko, Dirk Kuypers, Roel Goldschmeding

Research output: Contribution to journalReview articleAcademicpeer-review

221 Citations (Scopus)

Abstract

Connective tissue growth factor, also known as CCN2, is a cysteine-rich matricellular protein involved in the control of biological processes, such as cell proliferation, differentiation, adhesion and angiogenesis, as well as multiple pathologies, such as tumor development and tissue fibrosis. Here, we describe the molecular and biological characteristics of CTGF, its regulation and various functions in the spectrum of development and regeneration to fibrosis. We further outline the preclinical and clinical studies concerning compounds targeting CTGF in various pathologies with the focus on heart, lung, liver, kidney and solid organ transplantation. Finally, we address the advances and pitfalls of translational fibrosis research and provide suggestions to move towards a better management of fibrosis.

Original languageEnglish
Pages (from-to)44-66
Number of pages23
JournalMatrix Biology
Volume68-69
DOIs
Publication statusPublished - Aug 2018
Externally publishedYes

Keywords

  • CCN2
  • Connective tissue growth factor
  • Fibrosis
  • Marker and therapeutic target
  • Matricellular protein

Cite this